Surmodics (SRDX)
NASDAQ:SRDX

SurModics (SRDX) Stock Price & Analysis

91 Followers

SRDX Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$16.00 - $39.99
Previous Close$19.02
Volume80.92K
Average Volume (3M)190.76K
Market Cap
$268.83M
Enterprise Value$278.95M
Total Cash (Recent Filing)$19.18M
Total Debt (Recent Filing)$29.30M
Price to Earnings (P/E)-7.4
Beta1.08
Aug 02, 2023
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-2.57
Shares Outstanding14,134,000
10 Day Avg. Volume101,082
30 Day Avg. Volume190,759
Standard Deviation0.11
R-Squared0.22
Alpha-0.02
Financial Highlights & Ratios
Price to Book (P/B)8.77
Price to Sales (P/S)9.88
Price to Cash Flow (P/CF)-11.10
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue2.71
Enterprise Value/Gross Profit3.70
Enterprise Value/Ebitda-15.03
Forecast
Price Target Upside254.89% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2


Financials

Annual

Risk Analysis

Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products

Product Insights

Sorry, No Data Available
There is no website visitor data available for this stock.

---

SRDX FAQ

What was Surmodics’s price range in the past 12 months?
Surmodics lowest stock price was $16.00 and its highest was $39.99 in the past 12 months.
    What is Surmodics’s market cap?
    Currently, no data Available
    When is Surmodics’s upcoming earnings report date?
    Surmodics’s upcoming earnings report date is Aug 02, 2023 which is in 59 days.
      How were Surmodics’s earnings last quarter?
      Surmodics released its earnings results on Apr 26, 2023. The company reported -$0.4 earnings per share for the quarter, beating the consensus estimate of -$0.549 by $0.149.
        Is Surmodics overvalued?
        According to Wall Street analysts Surmodics’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
          Does Surmodics pay dividends?
          Surmodics does not currently pay dividends.
          What is Surmodics’s EPS estimate?
          Surmodics’s EPS estimate is -$0.5.
            How many shares outstanding does Surmodics have?
            Surmodics has 14,134,000 shares outstanding.
              What happened to Surmodics’s price movement after its last earnings report?
              Surmodics reported an EPS of -$0.4 in its last earnings report, beating expectations of -$0.549. Following the earnings report the stock price went up 1.551%.
                Which hedge fund is a major shareholder of Surmodics?
                Among the largest hedge funds holding Surmodics’s share is Royce & Associates LLC. It holds Surmodics’s shares valued at 7M.

                  ---

                  SurModics Stock Smart Score

                  The SurModics stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
                  Learn more about TipRanks Smart Score

                  Company Description

                  Surmodics

                  SurModics, Inc. engages in the provision of medical device and in vitro diagnostic technologies to the healthcare industry. It operates through the Medical Device and In Vitro Diagnostics segments. The Medical Device segment designs, develops, and manufactures interventional medical devices, surface modification coating technologies, as well as drug-delivery coating technologies. The In Vitro Diagnostics segment consists of component products and technologies for diagnostic test kits and biomedical research applications. The company was founded in June 1979 and is headquartered in Eden Prairie, MN.

                  ---

                  Top 5 ETFs holding SRDX

                  Name
                  Market Value
                  Smart Score
                  iShares U.S. Medical Devices ETF
                  $1.41M
                  8
                  Vanguard Health Care ETF
                  $1.10M
                  8
                  iShares Core S&P Total U.S. Stock Market ETF
                  $257.95K
                  8
                  Schwab U.S. Broad Market ETF
                  $145.37K
                  8
                  iShares Russell 3000 ETF
                  $69.40K
                  8
                  Up to five ETFs with an Outperform Smart Score that hold SRDX. The ETFs are listed according to market value of SRDX within the ETF

                  ---

                  Forecast EPS vs Actual EPS


                  Similar Stocks
                  Company
                  Price & Change
                  Follow
                  AC Immune SA
                  Innoviva
                  Kala Pharmaceuticals
                  Kodiak Sciences

                  Popular Stocks

                  ---
                  What's Included in PREMIUM?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis